Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
218.66
-0.91 (-0.41%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,021,536
Open
219.04
Bid (Size)
218.75 (100)
Ask (Size)
219.45 (100)
Prev. Close
219.57
Today's Range
218.13 - 220.11
52wk Range
141.50 - 220.11
Shares Outstanding
2,628,679,824
Dividend Yield
2.38%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wall Street’s Comeback King: Citigroup Shatters M&A Records as Jane Fraser Sets a High Bar for 2026
January 16, 2026
Citigroup Inc. (NYSE: C) has emerged from its multi-year restructuring with a historic performance in its investment banking division, reporting record-breaking M&A advisory revenue for the 2025 fiscal...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Wall Street Renaissance: Goldman Sachs Posts Record $9.3 Billion in Fees as Dealmaking Roars Back
January 16, 2026
On January 15, 2026, Goldman Sachs (NYSE: GS) silenced critics of its strategic pivot by reporting a powerhouse fourth-quarter performance for 2025, headlined by a staggering $9.34 billion in annual...
Via
MarketMinute
Topics
Credit Cards
Earnings
Economy
Performance
YTD
+5.5%
+5.5%
1 Month
+4.0%
+4.0%
3 Month
+13.2%
+13.2%
6 Month
+33.6%
+33.6%
1 Year
+48.0%
+48.0%
More News
Read More
Citigroup Shakes Up Wall Street with Record M&A Revenue as Global Dealmaking Thaws
January 15, 2026
Via
MarketMinute
Topics
Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Dependable Dividend Stock
↗
January 15, 2026
Via
Chartmill
"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Johnson & Johnson Drug Slows Blood Cancer, Extends Survival In Pretreated Patients
↗
January 15, 2026
Via
Benzinga
Topics
Death
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Earnings
FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel
January 14, 2026
Via
MarketMinute
Topics
Bankruptcy
US Current Account Deficit Narrows to $226.4 Billion in Q3 2025: An Analysis of the Shift
January 14, 2026
Via
MarketMinute
Topics
Economy
World Trade
The 'Beautiful' Boom: How the 2025 Tax Overhaul is Fueling a 2026 Corporate Spending Spree
January 14, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
January 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Court Orders Recalculation Of Damages In Johnson & Johnson Auris Case
↗
January 13, 2026
Via
Benzinga
The Evolution of a Giant: A Deep Dive into the ‘New’ Johnson & Johnson (JNJ) in 2026
January 13, 2026
Via
PredictStreet
Topics
Artificial Intelligence
Bankruptcy
Economy
2 No-Brainer Dividend Stocks to Buy Right Now
↗
January 13, 2026
Via
The Motley Fool
Topics
World Trade
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
↗
January 09, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
The Grinch Who Stole Wall Street: Santa Claus Rally Fails for Third Straight Year, Echoing 1950s Slump
January 09, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
January 09, 2026
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts
↗
January 09, 2026
Via
Benzinga
Topics
Government
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
January 08, 2026
From
Johnson & Johnson
Via
Business Wire
Johnson’s Junk Removal Launches Full-Service Junk Removal in Kenmore
January 08, 2026
Via
Get News
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
January 07, 2026
From
Johnson & Johnson
Via
Business Wire
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 218.66
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 01/16/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 574.79B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 575B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.